NCT07660211
- Conditions
- PSMA-positive Metastatic Castration-resistant Prostate Cancer (mCRPC)
- Locations
-
- Zhong Shan Hospital Fudan University Shanghai, Shanghai Municipality, China
Clinical trial condition
PSMA-positive Metastatic Castration-resistant Prostate Cancer (mCRPC)
Explore clinical trials studying PSMA-positive Metastatic Castration-resistant Prostate Cancer (mCRPC). Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study